Kom igång
AlenCiken

established a Scientific Advisory Board (SAB) and has appointed

Utbildning
Adial Pharmaceuticals, Inc (NASDAQ:ADIL)  
AlenCiken  
NASDAQ:ADIL   Adial Pharmaceuticals, Inc
Trend Analysis Chart Patterns Technical Indicators
0
0
trendanalysis chartpattern indicator
Adial Pharmaceuticals, Inc. today announced that it has established a Scientific Advisory Board (SAB) and has appointed Dr. Giovanni Addolorato, a leading global expert in the field of alcohol use disorder (AUD), as its first member and Chairperson. The SAB will help to guide the Company’s strategy and advance AD04, its lead therapeutic agent for AUD, with Phase 3 trials expected to commence in the first half of 2019.

globenewswire.com/ne...ol-Use-Disorder.html

seekingalpha.com/new...restoration-robotics

Frånsägelse av ansvar

Informationen och publikationerna är inte avsedda att vara, och utgör inte heller finansiella, investerings-, handels- eller andra typer av råd eller rekommendationer som tillhandahålls eller stöds av TradingView. Läs mer i Användarvillkoren.